Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adult Patients

NCT01765920 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT01765920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01765920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adult Patients
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2012
Completion date
April 30, 2015
Enrollment
342 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute upper respiratory tract infections